From the 35th Annual Meeting - Las Vegas, Nevada- November 2006
The file you requested will begin playing automatically. If it does not, press the 'play' button. If you experience playback problems, make certain you have the latest version of Windows Media Player, available here. If you have the latest Windows Media Player and still experience problems, email the OBGYN.net Webmaster with a description of the problem and any error messages you may have received.
HP-hMG stimulation reduces OHSS risk in high responder patients
October 25th 2024A recent study found that highly purified human menotropin significantly lowers the risk of ovarian hyperstimulation syndrome compared to recombinant follicle stimulating hormone, highlighting the benefits of protocol individualization based on gonadotropin type.
Read More